Targeted Oncology

Treating Together

Health EN ↓ 102 episodes

Targeted Oncology brings you Treating Together , a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Be sure to visit the podcast's website and support the creator: www.targetedonc.com

Author

Targeted Oncology

Category

Health

Podcast website

www.targetedonc.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

S7 Ep6: Navigating the Future of CLL Care 04.02.2026

In this episode of Treating Together, host Marc Braunstein, MD, an associate professor of medicine at the Perlmutter Cancer Center, NYU Grossman School of Medicine, is joined by John Burke, MD, from Rocky Mountain Cancer Centers. Both specialists bring their extensive experience in lymphoma and multiple myeloma to a deep-dive discussion on the rapidly evolving treatment landscape of chronic lympho...

S7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi 21.01.2026

This episode of Treating Together, hosted by Chandler Park, MD, featuring guests Benjamin Garmezy, MD, and Manoj Bupathi, MD,  centers on the intersection of clinical research and community oncology, specifically within the field of genitourinary (GU) oncology. Core Themes and Discussion Points The Community Oncology Gap: Park highlights a critical statistic: 80% to 85 % of patients with cancer ar...

S7 Ep4: Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD 15.12.2025
S7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers 31.10.2025

Benjamin Garmezy, MD, and Alexander Kenigsberg, MD, discuss strategies for preserving organs in GU cancers in the Treating Together podcast.

S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access 29.09.2025

Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss advancing lung cancer care and tackling real-world access barriers for community physicians.

S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making 31.07.2025

In our first episode of Treating Together, Benjamin Garmezy, MD, and Ralph J. Miller Jr, MD, discuss multidisciplinary prostate cancer care.

S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning 15.04.2025

 In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego, shed light on innovative research leveraging deep learning to predict how patients with ER-positive/HER2-negative (ER+/HER2-) breast cancer will respond to palbociclib (Ibrance), a common first-line treatment for this patient population. Thei...

S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall 13.03.2025

In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.

S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain 27.02.2025

David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.

S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia 06.02.2025

In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment 15.01.2025

In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.

S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research 14.11.2024

In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.

S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander 31.10.2024

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.

S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology 17.10.2024

Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.

S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer 26.09.2024

In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD tr...

S5 Ep16: Foran Goes Beyond the Basics of BPDCN 17.09.2024

In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.  

S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates 30.08.2024

In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.

S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel 15.08.2024

In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.

S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US 01.08.2024

In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.  

S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role 15.07.2024

In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma. 

S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine 01.07.2024

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.

S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM 14.06.2024

In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.

S5 Ep9: Unlocking the Potential of Technology in Community Oncology 15.05.2024

In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting. 

S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology 01.05.2024

In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.

S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches 15.04.2024

In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing...

Listen to the Treating Together podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.